Classifying Your Heart Attack: STEMI, NSTEMI, and Beyond
At a Glance
Doctors classify a heart attack by combining symptoms, ECG findings, troponin levels, and angiography. STEMI often signals a major blocked artery needing immediate reperfusion, while NSTEMI can also involve a complete blockage and requires urgent, risk-based evaluation.
The medical terms used to describe a heart attack can feel like an alphabet soup of acronyms. While these terms may sound interchangeable, they actually tell your doctors exactly what is happening in your heart and how quickly they need to act. Understanding these classifications—and the tools used to make them—helps clarify the path of your treatment.
The Foundation: ECG and Troponin
To classify a heart event, doctors rely on two primary pieces of evidence:
- The Electrocardiogram (ECG): This test records the electrical activity of your heart. Doctors look specifically at a part of the wave called the ST-segment. If this segment is significantly raised (elevated), it often indicates that a major artery is completely blocked [1][2].
- Cardiac Troponin: This is a protein found specifically in heart muscle cells. When heart cells are damaged or dying, they leak troponin into the bloodstream [3]. Modern “high-sensitivity” troponin tests can detect even tiny amounts of damage very quickly. However, elevated troponin alone simply proves injury to the heart; a diagnosis of a heart attack requires clinical evidence (like chest pain or ECG changes) that the injury was caused by restricted blood flow [4][5].
The Three Major Categories
These two tests allow doctors to sort acute coronary syndrome (ACS) into three main types:
- STEMI (ST-Elevation Myocardial Infarction): The ECG shows a clear elevation in the ST-segment. This usually represents a sudden blockage of a major coronary artery [1]. Because the heart muscle is rapidly losing oxygen, the goal for a STEMI is immediate “reperfusion”—opening the artery as fast as possible, usually in the cardiac catheterization lab [2].
- NSTEMI (Non-ST-Elevation Myocardial Infarction): The ECG does not show the classic ST-elevation, but blood tests show elevated troponin and clinical signs point to restricted blood flow [1][6]. An NSTEMI is highly variable: it can result from a complete blockage, a partial or transient blockage, small-vessel disease, or non-atherothrombotic causes. The urgency of an angiogram depends on your specific risk and stability. High-risk patients with ongoing pain or instability need immediate intervention, while more stable patients often undergo an angiogram soon after, typically within 24 to 48 hours depending on risk-based guidance [7].
- Unstable Angina: You have symptoms of a heart attack, and your ECG might show changes, but your troponin levels remain normal [1][2]. This suggests that while blood flow is restricted, heart muscle cells have not yet begun to die.
Type 1 vs. Type 2: Why it Matters
Not all heart attacks are caused by a blood clot. Doctors now distinguish between Type 1 and Type 2 Myocardial Infarction:
- Type 1 MI: This is the “classic” heart attack caused by a plaque rupture or erosion that triggers a clot [2].
- Type 2 MI: This happens when there is a “supply-and-demand” imbalance. Your heart needs more oxygen than it is getting, but there isn’t a sudden clot [2]. This can be triggered by extreme stressors like a severe infection (sepsis), very high heart rates, or severe anemia [8][9].
MINOCA and Alternative Diagnoses
Sometimes, a patient has all the signs of a heart attack, but when doctors perform an angiogram, the arteries look relatively clear (less than 50% blocked). After other explanations have been considered, this working diagnosis is called MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries) [10].
In these cases, doctors must carefully evaluate for alternative diagnoses or “look-alike” conditions, including:
- Takotsubo Syndrome: Often called “broken heart syndrome,” this is a temporary weakening of the heart muscle often triggered by extreme emotional or physical stress. It is an alternative diagnosis to MINOCA [11][12].
- SCAD (Spontaneous Coronary Artery Dissection): A rare but serious event where a tear occurs within the wall of the artery, blocking blood flow. This is a cause of MINOCA and is most common in younger women who may not have traditional heart disease risk factors [13][14].
- Myocarditis: Inflammation of the heart muscle, often caused by a viral infection [15].
- Pulmonary Embolism (PE) or Aortic Dissection: These are non-heart conditions (a blood clot in the lung or a tear in the body’s main artery) that can cause chest pain and troponin elevations similar to a heart attack [10][16].
The OMI/NOMI Framework: An Emerging View
You might hear your care team mention OMI (Occlusion Myocardial Infarction) or NOMI (Non-Occlusion MI). This is a newer way of thinking that some experts are pushing for as an emerging framework [17].
The OMI framework argues that the current “STEMI vs. NSTEMI” system is imperfect because up to 25–30% of NSTEMI patients actually have a completely blocked artery that doesn’t show the “classic” ST-elevation on an ECG [18][19]. These patients might benefit from the same immediate, emergency intervention as STEMI patients [20]. While not yet the universal standard in all hospitals, this approach is gaining traction as a way to identify high-risk patients who might otherwise be overlooked [21][17].
Common questions in this guide
What is the difference between a STEMI and an NSTEMI?
Does a high troponin level always mean I had a heart attack?
What is the difference between a Type 1 and Type 2 heart attack?
What does MINOCA mean if my angiogram looked clear?
Can an NSTEMI still be caused by a completely blocked artery?
When might someone with NSTEMI need an angiogram?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did my ECG show ST-elevation (STEMI) or was it classified as NSTEMI?
- 2.Based on my tests, do I have a 'Type 1' event caused by a clot, or a 'Type 2' event caused by another stressor?
- 3.If my arteries looked clear on the angiogram, what other conditions were evaluated to explain my symptoms?
- 4.What was the peak level of my high-sensitivity troponin, and how did it change over the first few hours?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (21)
- 1
[Management of acute coronary syndrome without ST-segment elevation].
Rubini Gimenez M, Thiele H, Pöss J
Herz 2022; (47(4)):381-392 doi:10.1007/s00059-022-05120-y.
PMID: 35699750 - 2
Contemporary NSTEMI management: the role of the hospitalist.
Pollack CV, Amin A, Wang T, et al.
Hospital practice (1995) 2020; (48(1)):1-11 doi:10.1080/21548331.2020.1701329.
PMID: 31815570 - 3
Diagnosis of unstable angina pectoris has declined markedly with the advent of more sensitive troponin assays.
D'Souza M, Sarkisian L, Saaby L, et al.
The American journal of medicine 2015; (128(8)):852-60.
PMID: 25820165 - 4
Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction.
Twerenbold R, Costabel JP, Nestelberger T, et al.
Journal of the American College of Cardiology 2019; (74(4)):483-494 doi:10.1016/j.jacc.2019.05.046.
PMID: 31345421 - 5
Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.
Wereski R, Kimenai DM, Taggart C, et al.
Circulation 2021; (144(7)):528-538 doi:10.1161/CIRCULATIONAHA.121.054302.
PMID: 34167318 - 6
Prevalence of Non-ST-Segment Elevation Myocardial Infarction in Acute Coronary Syndrome With Unremarkable Electrocardiogram: A Cross-Sectional Study From Lady Reading Hospital, Medical Teaching Institute, Peshawar.
Zeb U, Khan NA, Ullah N, Khan MH
Cureus 2024; (16(9)):e70575 doi:10.7759/cureus.70575.
PMID: 39483937 - 7
Gender-specific diagnostic performance of a new high-sensitivity cardiac troponin I assay for detection of acute myocardial infarction.
Schofer N, Brunner FJ, Schlüter M, et al.
European heart journal. Acute cardiovascular care 2017; (6(1)):60-68 doi:10.1177/2048872615626660.
PMID: 26772795 - 8
Impact of Type 2 Myocardial Infarction (MI) on Hospital-Level MI Outcomes: Implications for Quality and Public Reporting.
Arora S, Strassle PD, Qamar A, et al.
Journal of the American Heart Association 2018; (7(7)) doi:10.1161/JAHA.118.008661.
PMID: 29581221 - 9
Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
Guimarães PO, Leonardi S, Huang Z, et al.
American heart journal 2018; (196()):28-35 doi:10.1016/j.ahj.2017.10.007.
PMID: 29421012 - 10
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.
Tamis-Holland JE, Jneid H, Reynolds HR, et al.
Circulation 2019; (139(18)):e891-e908 doi:10.1161/CIR.0000000000000670.
PMID: 30913893 - 11
Takotsubo Syndrome Presenting as ST-Elevation Myocardial Infarction With Concomitant Persistent High-Grade AV Block Requiring Cardiac Resynchronisation Therapy Pacemaker.
Solano J, Hussain A, Ahmed A, et al.
Case reports in cardiology 2026; (2026()):1482184 doi:10.1155/cric/1482184.
PMID: 41769221 - 12
Etiology of Acute Coronary Syndrome after Noncardiac Surgery.
Helwani MA, Amin A, Lavigne P, et al.
Anesthesiology 2018; (128(6)):1084-1091 doi:10.1097/ALN.0000000000002107.
PMID: 29481375 - 13
The presentation of spontaneous coronary artery dissection in the emergency department: Signs and symptoms in an unsuspecting population.
Johnson AK, Tweet MS, Rouleau SG, et al.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2022; (29(4)):423-428 doi:10.1111/acem.14426.
PMID: 34897898 - 14
Current state-of-play in spontaneous coronary artery dissection.
Franke KB, Wong DTL, Baumann A, et al.
Cardiovascular diagnosis and therapy 2019; (9(3)):281-298 doi:10.21037/cdt.2019.04.03.
PMID: 31275818 - 15
MINOCA: One Size Fits All? Probably Not-A Review of Etiology, Investigation, and Treatment.
Herling de Oliveira LL, Correia VM, Nicz PFG, et al.
Journal of clinical medicine 2022; (11(19)) doi:10.3390/jcm11195497.
PMID: 36233366 - 16
Myocardial infarction with non-obstructive coronary arteries (MINOCA).
Yildiz M, Ashokprabhu N, Shewale A, et al.
Frontiers in cardiovascular medicine 2022; (9()):1032436 doi:10.3389/fcvm.2022.1032436.
PMID: 36457805 - 17
Acute coronary-occlusion myocardial infarctions: performance of the STEMI criteria and evolving alternative approaches.
Tudino R, Richardson E, Gonzalez JM, et al.
Trends in cardiovascular medicine 2026; (36(3)):180-187 doi:10.1016/j.tcm.2025.10.006.
PMID: 41120030 - 18
Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
Khan AR, Golwala H, Tripathi A, et al.
European heart journal 2017; (38(41)):3082-3089 doi:10.1093/eurheartj/ehx418.
PMID: 29020244 - 19
Comparison of the ST-Elevation Myocardial Infarction (STEMI) vs. NSTEMI and Occlusion MI (OMI) vs. NOMI Paradigms of Acute MI.
Meyers HP, Bracey A, Lee D, et al.
The Journal of emergency medicine 2021; (60(3)):273-284 doi:10.1016/j.jemermed.2020.10.026.
PMID: 33308915 - 20
Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality.
Abusharekh M, Kampf J, Dykun I, et al.
European heart journal. Quality of care & clinical outcomes 2024; (10(5)):402-410 doi:10.1093/ehjqcco/qcae003.
PMID: 38192031 - 21
Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction.
Pendell Meyers H, Bracey A, Lee D, et al.
International journal of cardiology. Heart & vasculature 2021; (33()):100767 doi:10.1016/j.ijcha.2021.100767.
PMID: 33912650
This page is for informational purposes only and does not constitute medical advice. It explains how clinicians classify possible heart attacks; seek emergency care for new or worsening chest pain or other concerning symptoms.
Get notified when new evidence is published on coronary thrombosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.